Hospital
Children's Hospital Medical Center of Akron
Children's Hospital Medical Center of Akron was paid $556.65M by Medicaid between Jan 2018 and Dec 2024, across 717 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 26% of everything it billed.
33Billing provider infoCHILDREN'S HOSPITAL MEDICAL CENTER OF AKRON
AKRON, OH 44308
AKRON, OH 44308
33aNPI1861506560assigned 08/18/2006
33bProvider typeChildren's Hospital
28Total paid$556.65M
24GClaims6,634,271
24DCodes billed717
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Children's Hospital providers in Ohio
Rank by total paid#1 of 7
Median peer was paid$12.53M
This provider vs. median44×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 627,653 | $40.13M | |
| 2019 | 706,416 | $43.44M | |
| 2020 | 598,283 | $55.74M | |
| 2021 | 670,508 | $65.08M | |
| 2022 | 726,281 | $67.62M | |
| 2023 | 1,880,867 | $147.39M | |
| 2024incomplete | 1,424,263 | $137.25M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 26% | 991,232 | 879,763 | $146.97M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 10% | 349,258 | 315,856 | $56.74M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.4% | 217,031 | 203,330 | $30.19M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.2% | 215,592 | 198,126 | $28.95M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 4.9% | 162,047 | 149,259 | $27.52M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 4.4% | 160,882 | 150,111 | $24.35M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.0% | 121,188 | 112,823 | $16.64M |
| 92551 | 2.3% | 142,134 | 131,235 | $12.96M | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 1.9% | 5,730 | 4,894 | $10.64M |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.8% | 61,517 | 54,598 | $10.11M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1.7% | 47,882 | 41,258 | $9.43M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.5% | 60,486 | 53,894 | $8.57M |
705 more codes
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.3% | 53,877 | $7.43M |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.1% | 58,158 | $6.13M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 44,510 | $5.54M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 21,560 | $5.33M |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 26,009 | $5.23M |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 3,361 | $5.20M |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 33,441 | $4.84M |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 8,598 | $4.80M |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 22,080 | $3.90M |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 33,594 | $3.69M |
| D2930 | Prefabricated stainless steel crown - primary tooth | <1% | 4,889 | $3.63M |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 1,621 | $2.92M |
| G0378 | Hospital observation service, per hour | <1% | 28,158 | $2.82M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 19,297 | $2.82M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 5,994 | $2.63M |
| 67311 | <1% | 808 | $2.55M | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 335,448 | $2.52M |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 14,065 | $2.52M |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 4,463 | $2.45M |
| 76770 | <1% | 9,722 | $2.45M | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 3,572 | $1.84M |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 12,762 | $1.81M |
| 93325 | <1% | 13,329 | $1.79M | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 4,858 | $1.79M |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 6,078 | $1.77M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 2,584 | $1.77M |
| 90839 | <1% | 8,979 | $1.75M | |
| 42830 | <1% | 1,253 | $1.70M | |
| 90899 | <1% | 12,528 | $1.69M | |
| 95812 | <1% | 1,239 | $1.63M | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 4,939 | $1.59M |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 5,595 | $1.53M |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 3,375 | $1.51M |
| 97803 | <1% | 11,833 | $1.37M | |
| 90686 | <1% | 145,580 | $1.36M | |
| 92567 | <1% | 29,352 | $1.14M | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 10,049 | $1.12M |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 1,010 | $1.10M |
| 54150 | <1% | 665 | $1.06M | |
| D3220 | Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction | <1% | 2,017 | $1.06M |
| 93304 | <1% | 2,140 | $1.05M | |
| 90670 | <1% | 102,394 | $1.01M | |
| Q5103 | Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg | <1% | 1,432 | $969K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 5,664 | $965K |
| A0427 | Emergency ambulance ride, advanced life support | <1% | 5,512 | $936K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 10,092 | $928K |
| 95716 | <1% | 713 | $920K | |
| A0425 | Ground mileage, per statute mile | <1% | 10,810 | $867K |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 3,281 | $855K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | <1% | 615 | $839K |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | <1% | 488 | $777K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 7,222 | $769K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 11,338 | $758K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 4,878 | $732K |
| A0434 | Specialty care transport (sct) | <1% | 3,749 | $727K |
| 95715 | <1% | 539 | $726K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 14,850 | $710K |
| 90837 | Psychotherapy session, about an hour | <1% | 3,472 | $695K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 1,950 | $688K |
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 1,231 | $679K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 836 | $671K |
| 83655 | <1% | 60,156 | $657K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 144,426 | $655K |
| 92523 | <1% | 5,644 | $638K | |
| D1351 | Sealant - per tooth | <1% | 1,080 | $636K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 5,404 | $611K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 3,825 | $602K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 1,290 | $585K |
| 95782 | <1% | 521 | $580K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 2,416 | $567K |
| 01922 | <1% | 1,873 | $559K | |
| 96415 | <1% | 1,035 | $557K | |
| 95117 | <1% | 12,823 | $556K | |
| 64643 | <1% | 886 | $554K | |
| 94762 | <1% | 7,527 | $552K | |
| 44970 | <1% | 181 | $533K | |
| 80053 | Comprehensive metabolic panel | <1% | 37,285 | $530K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 2,740 | $523K |
| 29075 | <1% | 2,651 | $510K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 1,136 | $484K |
| 97802 | <1% | 4,123 | $482K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 1,266 | $478K |
| 81229 | <1% | 638 | $478K | |
| 90633 | <1% | 49,274 | $475K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 36,588 | $469K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 5,732 | $456K |
| 92588 | <1% | 3,166 | $448K | |
| 97162 | <1% | 3,998 | $447K | |
| 41010 | <1% | 347 | $442K | |
| 17110 | <1% | 1,865 | $433K | |
| 92555 | <1% | 11,172 | $432K | |
| D2330 | <1% | 723 | $430K | |
| 76801 | <1% | 1,997 | $428K | |
| 16020 | <1% | 3,595 | $424K | |
| 97161 | <1% | 3,645 | $394K | |
| 95700 | <1% | 1,773 | $391K | |
| 94010 | <1% | 10,193 | $391K | |
| 96127 | <1% | 5,457 | $391K | |
| 90698 | <1% | 50,852 | $377K | |
| 92526 | <1% | 3,737 | $376K | |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 909 | $373K |
| 97166 | <1% | 2,372 | $371K | |
| 90697 | <1% | 35,471 | $366K | |
| 74230 | <1% | 1,504 | $358K | |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | <1% | 1,082 | $346K |
| 92579 | <1% | 2,579 | $338K | |
| 96156 | <1% | 1,008 | $334K | |
| 97116 | <1% | 4,289 | $328K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 1,278 | $320K |
| 76000 | <1% | 2,037 | $316K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 1,127 | $312K |
| 54161 | <1% | 202 | $311K | |
| 96161 | <1% | 4,587 | $307K | |
| A0431 | Ambulance service, conventional air services, transport, one way (rotary wing) | <1% | 170 | $303K |
| 96158 | <1% | 2,699 | $302K | |
| D1510 | <1% | 466 | $299K | |
| 90680 | <1% | 59,557 | $294K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 186,166 | $290K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 22,548 | $290K |
| 70491 | <1% | 607 | $286K | |
| 93308 | <1% | 530 | $280K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 62,385 | $275K |
| 93975 | <1% | 1,764 | $272K | |
| 76825 | <1% | 1,672 | $269K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 61,629 | $268K |
| D2740 | Crown - porcelain/ceramic | <1% | 285 | $265K |
| 74018 | <1% | 8,475 | $261K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 728 | $260K |
| 12011 | <1% | 1,000 | $246K | |
| 93976 | <1% | 974 | $241K | |
| 76820 | <1% | 2,532 | $238K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 24,485 | $232K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 30,236 | $223K |
| 12001 | <1% | 875 | $216K | |
| 92587 | <1% | 1,745 | $216K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 17,147 | $213K |
| 93226 | <1% | 1,243 | $210K | |
| 76857 | <1% | 1,441 | $209K | |
| 49452 | <1% | 586 | $205K | |
| 29425 | <1% | 1,044 | $205K | |
| D2390 | <1% | 337 | $205K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 21,223 | $200K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 15,575 | $200K |
| 36415 | Collection of venous blood by venipuncture | <1% | 92,642 | $199K |
| 97167 | <1% | 1,123 | $185K | |
| 74240 | <1% | 828 | $185K | |
| 84439 | <1% | 10,787 | $184K | |
| 76536 | <1% | 1,175 | $173K | |
| 90744 | <1% | 21,814 | $173K | |
| 29065 | <1% | 869 | $173K | |
| 70486 | <1% | 866 | $170K | |
| 80061 | Lipid panel | <1% | 15,028 | $169K |
| 92611 | <1% | 1,485 | $167K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 1,124 | $166K |
| 86140 | <1% | 22,157 | $164K | |
| 11900 | <1% | 647 | $164K | |
| 90651 | <1% | 17,980 | $163K | |
| 96160 | <1% | 4,506 | $160K | |
| 97168 | <1% | 1,050 | $160K | |
| 97164 | <1% | 1,359 | $160K | |
| 76827 | <1% | 1,665 | $159K | |
| 97760 | <1% | 1,399 | $157K | |
| 97165 | <1% | 1,044 | $157K | |
| 92508 | Group treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 1,242 | $151K |
| 92250 | <1% | 2,565 | $149K | |
| 92652 | <1% | 1,203 | $148K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 26,286 | $143K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 4,843 | $142K |
| 90619 | <1% | 14,138 | $142K | |
| 96132 | <1% | 568 | $139K | |
| D2393 | Resin-based composite - three surfaces, posterior, primary or permanent | <1% | 452 | $137K |
| 70360 | <1% | 2,850 | $137K | |
| 90677 | <1% | 14,908 | $136K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 13,819 | $134K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 9,276 | $133K |
| 90480 | <1% | 4,825 | $131K | |
| 96130 | <1% | 528 | $127K | |
| 82728 | <1% | 9,564 | $127K | |
| 76885 | <1% | 807 | $126K | |
| 96116 | <1% | 403 | $126K | |
| 96138 | <1% | 658 | $122K | |
| 12051 | <1% | 457 | $121K | |
| 83516 | <1% | 6,714 | $121K | |
| 92557 | <1% | 943 | $118K | |
| 87507 | <1% | 938 | $116K | |
| 95819 | <1% | 402 | $111K | |
| 95811 | <1% | 90 | $110K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 655 | $109K |
| 76800 | <1% | 632 | $109K | |
| 10060 | <1% | 411 | $107K | |
| 92610 | <1% | 1,490 | $106K | |
| 90620 | <1% | 5,396 | $106K | |
| 76882 | <1% | 881 | $104K | |
| 74019 | <1% | 12,133 | $102K | |
| 90696 | <1% | 12,509 | $102K | |
| 29085 | <1% | 522 | $101K | |
| 95076 | <1% | 243 | $101K | |
| 99442 | <1% | 542 | $97K | |
| 80069 | <1% | 4,833 | $92K | |
| C9285 | Lidocaine 70 mg/tetracaine 70 mg, per patch | <1% | 1,548 | $91K |
| 24538 | <1% | 13 | $90K | |
| 82784 | <1% | 7,316 | $89K | |
| 90715 | <1% | 10,230 | $89K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 558 | $89K |
| 42821 | <1% | 41 | $88K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 24,740 | $87K |
| 36000 | <1% | 1,202 | $86K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 9,275 | $85K |
| 00170 | Anesthesia for intraoral procedures, including biopsy | <1% | 18,858 | $84K |
| 90785 | <1% | 1,325 | $83K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 1,048 | $82K |
| 95951 | <1% | 127 | $82K | |
| 49591 | <1% | 36 | $81K | |
| 51784 | <1% | 213 | $81K | |
| 76813 | <1% | 656 | $80K | |
| 90648 | <1% | 9,834 | $79K | |
| 90716 | <1% | 12,110 | $78K | |
| 92556 | <1% | 1,182 | $77K | |
| 87081 | <1% | 31,932 | $74K | |
| 90685 | <1% | 8,556 | $74K | |
| 90710 | <1% | 14,481 | $72K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 8,013 | $71K |
| 76937 | <1% | 1,156 | $68K | |
| 85027 | <1% | 14,298 | $67K | |
| 64642 | <1% | 851 | $67K | |
| 0071A | <1% | 1,880 | $66K | |
| 97113 | <1% | 519 | $65K | |
| 90700 | <1% | 12,096 | $64K | |
| 90707 | <1% | 12,036 | $64K | |
| 80076 | <1% | 6,047 | $63K | |
| 0154A | <1% | 1,599 | $62K | |
| A0426 | Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) | <1% | 339 | $61K |
| 77072 | <1% | 1,488 | $60K | |
| 72081 | <1% | 1,286 | $59K | |
| 94060 | <1% | 469 | $59K | |
| 96367 | <1% | 546 | $59K | |
| A0436 | Rotary wing air mileage, per statute mile | <1% | 168 | $58K |
| 0124A | <1% | 1,569 | $57K | |
| A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | <1% | 365 | $55K |
| G0168 | Wound closure utilizing tissue adhesive(s) only | <1% | 207 | $54K |
| 83540 | <1% | 6,734 | $54K | |
| 93225 | <1% | 1,052 | $54K | |
| 96139 | <1% | 656 | $54K | |
| 77075 | <1% | 300 | $53K | |
| 97750 | <1% | 610 | $52K | |
| 90846 | Family psychotherapy without the patient present, 50 minutes | <1% | 247 | $52K |
| 81001 | <1% | 31,631 | $50K | |
| 0081A | <1% | 1,636 | $49K | |
| 76506 | <1% | 303 | $49K | |
| 54163 | <1% | 31 | $48K | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 833 | $46K |
| 86003 | <1% | 4,581 | $46K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 55,513 | $45K |
| 83550 | <1% | 6,670 | $43K | |
| 86850 | <1% | 1,346 | $42K | |
| 95115 | <1% | 903 | $41K | |
| 0072A | <1% | 1,183 | $41K | |
| 69610 | <1% | 35 | $39K | |
| 92552 | <1% | 1,410 | $39K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 427 | $38K |
| 87077 | <1% | 9,276 | $37K | |
| 83520 | <1% | 2,243 | $37K | |
| 90656 | <1% | 3,908 | $37K | |
| 73610 | <1% | 4,685 | $35K | |
| 81002 | <1% | 33,880 | $34K | |
| 72141 | <1% | 162 | $34K | |
| 97014 | <1% | 721 | $34K | |
| 90474 | <1% | 45,233 | $33K | |
| 96111 | <1% | 141 | $33K | |
| 73630 | <1% | 4,382 | $33K | |
| 81243 | <1% | 177 | $32K | |
| 11102 | <1% | 40 | $32K | |
| 73521 | <1% | 1,533 | $32K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 64 | $31K |
| 97763 | <1% | 315 | $30K | |
| 72197 | <1% | 51 | $29K | |
| 0082A | <1% | 863 | $29K | |
| 87493 | <1% | 631 | $28K | |
| 73562 | <1% | 2,524 | $28K | |
| 99443 | <1% | 152 | $27K | |
| 73140 | <1% | 3,998 | $27K | |
| 86880 | <1% | 1,546 | $27K | |
| 84460 | <1% | 5,639 | $26K | |
| 91320 | <1% | 1,040 | $26K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 27,098 | $26K |
| 0001A | <1% | 957 | $26K | |
| 85652 | <1% | 6,390 | $26K | |
| J3590 | Unclassified biologics | <1% | 35 | $25K |
| 86900 | <1% | 1,556 | $25K | |
| 76870 | <1% | 965 | $25K | |
| 80197 | <1% | 1,169 | $24K | |
| 73110 | <1% | 3,644 | $24K | |
| D2331 | <1% | 60 | $24K | |
| 99156 | <1% | 331 | $24K | |
| 97150 | Therapeutic procedure(s), group (2 or more individuals) | <1% | 201 | $23K |
| 99441 | <1% | 135 | $23K | |
| 81025 | <1% | 19,133 | $23K | |
| 85610 | <1% | 3,413 | $23K | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 26,964 | $23K |
| 00120 | <1% | 473 | $23K | |
| 86665 | <1% | 2,010 | $23K | |
| 82947 | <1% | 2,939 | $22K | |
| 29405 | <1% | 115 | $22K | |
| 73130 | <1% | 3,738 | $22K | |
| 74455 | <1% | 145 | $22K | |
| 85018 | <1% | 41,216 | $22K | |
| 82977 | <1% | 2,233 | $21K | |
| 83970 | <1% | 954 | $21K | |
| 92545 | <1% | 184 | $20K | |
| 92582 | <1% | 298 | $20K | |
| 20680 | <1% | 15 | $20K | |
| 91319 | <1% | 1,397 | $20K | |
| 83993 | <1% | 826 | $20K | |
| 00400 | <1% | 782 | $20K | |
| 92133 | <1% | 357 | $20K | |
| 0002A | <1% | 722 | $20K | |
| 83735 | <1% | 3,569 | $20K | |
| 86592 | <1% | 1,239 | $20K | |
| 72082 | <1% | 756 | $19K | |
| 73090 | <1% | 2,739 | $19K | |
| 83001 | <1% | 1,495 | $18K | |
| 96152 | <1% | 150 | $18K | |
| 73590 | <1% | 2,076 | $18K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 546 | $18K |
| 92607 | <1% | 254 | $18K | |
| 82533 | <1% | 775 | $18K | |
| 84305 | <1% | 1,099 | $18K | |
| 90734 | <1% | 2,630 | $18K | |
| 84403 | <1% | 1,775 | $17K | |
| 82670 | <1% | 1,055 | $17K | |
| 87186 | <1% | 7,303 | $17K | |
| 83525 | <1% | 727 | $17K | |
| D2140 | <1% | 30 | $17K | |
| 83002 | <1% | 1,536 | $17K | |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | <1% | 2,324 | $17K |
| 82248 | <1% | 3,956 | $17K | |
| 86480 | <1% | 716 | $16K | |
| 85397 | <1% | 666 | $16K | |
| 91318 | <1% | 1,383 | $16K | |
| 82607 | <1% | 1,059 | $16K | |
| 86317 | <1% | 1,636 | $16K | |
| 83021 | <1% | 1,221 | $16K | |
| 82272 | <1% | 1,746 | $16K | |
| 80164 | <1% | 744 | $15K | |
| 95079 | <1% | 122 | $15K | |
| 82962 | <1% | 6,233 | $15K | |
| 74183 | <1% | 58 | $15K | |
| 82247 | <1% | 3,473 | $15K | |
| 86580 | <1% | 779 | $14K | |
| 90381 | <1% | 1,816 | $14K | |
| 85246 | <1% | 752 | $14K | |
| 83690 | <1% | 5,209 | $14K | |
| 92134 | <1% | 396 | $14K | |
| 86376 | <1% | 1,035 | $14K | |
| D2335 | <1% | 13 | $14K | |
| 80074 | <1% | 760 | $14K | |
| 94760 | <1% | 31,968 | $14K | |
| 85240 | <1% | 712 | $14K | |
| 82627 | <1% | 798 | $14K | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 8,819 | $14K |
| 90380 | <1% | 1,903 | $14K | |
| 77074 | <1% | 1,228 | $14K | |
| 99157 | <1% | 424 | $14K | |
| 87070 | <1% | 3,955 | $14K | |
| 70480 | <1% | 54 | $13K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 9,114 | $13K |
| 84146 | <1% | 827 | $13K | |
| 73080 | <1% | 1,818 | $13K | |
| 92015 | Determination of refractive state | <1% | 1,141 | $13K |
| 86256 | <1% | 913 | $13K | |
| 92541 | <1% | 184 | $13K | |
| 82570 | <1% | 2,112 | $13K | |
| 72170 | <1% | 929 | $13K | |
| 86803 | <1% | 615 | $12K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,278 | $12K |
| 70543 | <1% | 18 | $12K | |
| 84100 | <1% | 3,571 | $12K | |
| 83498 | <1% | 882 | $12K | |
| 87328 | <1% | 787 | $12K | |
| 97032 | <1% | 194 | $12K | |
| 72100 | <1% | 923 | $12K | |
| 82785 | <1% | 1,401 | $12K | |
| 72040 | <1% | 868 | $12K | |
| 36416 | <1% | 82,791 | $12K | |
| 92558 | <1% | 198 | $11K | |
| 73030 | <1% | 1,181 | $11K | |
| 96118 | <1% | 116 | $11K | |
| 73100 | <1% | 1,413 | $11K | |
| 82550 | <1% | 1,676 | $11K | |
| 82024 | <1% | 326 | $11K | |
| 73564 | <1% | 1,150 | $11K | |
| 76010 | <1% | 922 | $11K | |
| 93320 | <1% | 3,929 | $11K | |
| 87045 | <1% | 891 | $11K | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | <1% | 757 | $11K |
| 86920 | <1% | 331 | $11K | |
| 85651 | <1% | 4,618 | $10K | |
| 87046 | <1% | 926 | $10K | |
| 95816 | <1% | 30 | $10K | |
| 87329 | <1% | 784 | $10K | |
| J2704 | Injection, propofol, 10 mg | <1% | 41,507 | $10K |
| D4342 | <1% | 18 | $10K | |
| 90713 | <1% | 1,820 | $10K | |
| 0479T | <1% | 27 | $10K | |
| 86038 | <1% | 662 | $10K | |
| 86308 | <1% | 2,290 | $10K | |
| 92201 | <1% | 166 | $9K | |
| 93321 | <1% | 2,897 | $9K | |
| 87899 | <1% | 1,539 | $9K | |
| 86901 | <1% | 1,542 | $9K | |
| 92542 | <1% | 184 | $9K | |
| 90473 | <1% | 483 | $9K | |
| 12002 | <1% | 30 | $9K | |
| 85046 | <1% | 4,034 | $9K | |
| 71045 | Radiologic examination, chest; single view | <1% | 1,000 | $9K |
| 84510 | <1% | 394 | $8K | |
| 81479 | Unlisted molecular pathology procedure | <1% | 762 | $8K |
| 77076 | <1% | 605 | $8K | |
| J7121 | 5% dextrose in lactated ringers infusion, up to 1000 cc | <1% | 1,340 | $8K |
| 84480 | <1% | 747 | $8K | |
| 40806 | <1% | 71 | $8K | |
| 96131 | <1% | 105 | $8K | |
| 87040 | <1% | 2,575 | $8K | |
| 83615 | <1% | 2,299 | $8K | |
| 84030 | <1% | 423 | $8K | |
| 87529 | <1% | 986 | $8K | |
| 72072 | <1% | 512 | $8K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 25,728 | $7K |
| 86800 | <1% | 778 | $7K | |
| 94664 | <1% | 5,733 | $7K | |
| 73000 | <1% | 844 | $7K | |
| 73552 | <1% | 709 | $7K | |
| 82157 | <1% | 360 | $7K | |
| D1120 | Dental cleaning, child | <1% | 1,760 | $7K |
| 92522 | <1% | 62 | $7K | |
| 85730 | <1% | 2,570 | $7K | |
| 86355 | <1% | 484 | $6K | |
| 84270 | <1% | 696 | $6K | |
| 96450 | <1% | 19 | $6K | |
| 73070 | <1% | 754 | $6K | |
| 84402 | <1% | 798 | $6K | |
| 82945 | <1% | 800 | $6K | |
| 90461 | <1% | 18,827 | $6K | |
| 0074A | <1% | 229 | $6K | |
| 00300 | <1% | 1,001 | $6K | |
| 91321 | <1% | 650 | $6K | |
| 74270 | <1% | 26 | $6K | |
| 82565 | <1% | 1,126 | $6K | |
| 80177 | <1% | 451 | $6K | |
| 70544 | <1% | 14 | $6K | |
| 82610 | <1% | 682 | $6K | |
| 86160 | <1% | 743 | $5K | |
| 70250 | <1% | 368 | $5K | |
| 82525 | <1% | 285 | $5K | |
| 73660 | <1% | 706 | $5K | |
| 51701 | <1% | 2,305 | $5K | |
| 0051A | <1% | 203 | $5K | |
| 51600 | <1% | 144 | $5K | |
| 84145 | <1% | 1,107 | $5K | |
| 80143 | <1% | 1,177 | $5K | |
| 00140 | <1% | 1,594 | $5K | |
| 31575 | <1% | 12 | $5K | |
| 73560 | <1% | 544 | $5K | |
| 86618 | <1% | 732 | $5K | |
| L8699 | Prosthetic implant, not otherwise specified | <1% | 65 | $5K |
| 90672 | <1% | 478 | $5K | |
| 86359 | <1% | 528 | $5K | |
| 86664 | <1% | 434 | $5K | |
| 73060 | <1% | 524 | $5K | |
| 87205 | <1% | 2,753 | $5K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 14 | $5K |
| 51728 | <1% | 18 | $5K | |
| 0052A | <1% | 119 | $4K | |
| 84450 | <1% | 611 | $4K | |
| 96120 | <1% | 20 | $4K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 39,687 | $4K |
| 86706 | <1% | 445 | $4K | |
| 0173A | <1% | 272 | $4K | |
| 92626 | <1% | 32 | $4K | |
| 82043 | <1% | 1,233 | $4K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 59,046 | $4K |
| 86360 | <1% | 484 | $4K | |
| 86357 | <1% | 486 | $4K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 210 | $4K |
| 84156 | <1% | 938 | $4K | |
| 87338 | <1% | 193 | $4K | |
| 84550 | <1% | 946 | $4K | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 10,561 | $4K |
| 82330 | <1% | 1,570 | $3K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 6,409 | $3K |
| 87808 | <1% | 592 | $3K | |
| 84703 | <1% | 1,139 | $3K | |
| 76830 | Ultrasound, transvaginal | <1% | 295 | $3K |
| 87340 | <1% | 215 | $3K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 3,381 | $3K |
| 91322 | <1% | 310 | $3K | |
| 82746 | <1% | 414 | $3K | |
| 76942 | <1% | 908 | $3K | |
| 97163 | <1% | 31 | $3K | |
| 84484 | <1% | 569 | $3K | |
| 97156 | <1% | 26 | $3K | |
| 87497 | <1% | 110 | $3K | |
| 00126 | <1% | 3,414 | $3K | |
| 82077 | <1% | 962 | $3K | |
| 96119 | <1% | 45 | $3K | |
| 87088 | <1% | 973 | $3K | |
| 92083 | <1% | 39 | $3K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 786 | $3K |
| 51797 | <1% | 17 | $3K | |
| 72146 | <1% | 68 | $3K | |
| 80339 | <1% | 98 | $3K | |
| 72020 | <1% | 213 | $3K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 26 | $3K |
| 36591 | <1% | 422 | $3K | |
| D0272 | Bitewings - two radiographic images | <1% | 4,037 | $3K |
| 0083A | <1% | 143 | $3K | |
| 51741 | <1% | 55 | $2K | |
| 80183 | <1% | 126 | $2K | |
| 87799 | <1% | 391 | $2K | |
| 88341 | <1% | 14 | $2K | |
| 00920 | <1% | 806 | $2K | |
| 84134 | <1% | 231 | $2K | |
| 83605 | <1% | 1,237 | $2K | |
| V5266 | Battery for use in hearing device | <1% | 577 | $2K |
| 86341 | <1% | 158 | $2K | |
| 82948 | <1% | 849 | $2K | |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 5,085 | $2K |
| 94726 | <1% | 32 | $2K | |
| 87634 | <1% | 1,034 | $2K | |
| J1815 | Injection, insulin, per 5 units | <1% | 162 | $2K |
| 86008 | <1% | 293 | $2K | |
| 82803 | <1% | 1,380 | $2K | |
| 96133 | <1% | 155 | $2K | |
| 80179 | <1% | 1,052 | $2K | |
| 29355 | <1% | 12 | $2K | |
| 87522 | Neg quan hep c or qual rna | <1% | 104 | $2K |
| 96381 | <1% | 111 | $2K | |
| 88300 | <1% | 5,357 | $2K | |
| 97018 | <1% | 37 | $2K | |
| 82105 | <1% | 136 | $2K | |
| 72110 | <1% | 55 | $2K | |
| 00731 | <1% | 1,389 | $2K | |
| 86225 | <1% | 231 | $2K | |
| 84132 | <1% | 1,194 | $2K | |
| 76642 | <1% | 15 | $2K | |
| 86663 | <1% | 169 | $2K | |
| V5264 | Ear mold/insert, not disposable, any type | <1% | 58 | $2K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 7,743 | $2K |
| 82140 | <1% | 125 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 5,600 | $2K |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | <1% | 7,074 | $2K |
| 84445 | <1% | 61 | $2K | |
| 84520 | <1% | 952 | $2K | |
| 71110 | <1% | 113 | $2K | |
| 84630 | <1% | 113 | $1K | |
| 96150 | <1% | 13 | $1K | |
| 96376 | <1% | 580 | $1K | |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | <1% | 1,485 | $1K |
| 86060 | <1% | 67 | $1K | |
| 84702 | <1% | 43 | $1K | |
| 82310 | <1% | 144 | $1K | |
| 76376 | <1% | 2,575 | $1K | |
| 80349 | <1% | 240 | $1K | |
| 86617 | <1% | 155 | $1K | |
| 86611 | <1% | 90 | $1K | |
| 83880 | <1% | 174 | $1K | |
| 82150 | <1% | 177 | $1K | |
| J0736 | Injection, clindamycin phosphate, 300 mg | <1% | 576 | $1K |
| 88304 | <1% | 1,259 | $1K | |
| 64644 | <1% | 16 | $1K | |
| 95713 | <1% | 13 | $1K | |
| 94761 | <1% | 48,035 | $1K | |
| 85576 | <1% | 38 | $1K | |
| 87536 | <1% | 53 | $1K | |
| 70310 | <1% | 4,729 | $1K | |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | <1% | 1,324 | $1K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 36,254 | $1K |
| 81374 | <1% | 26 | $1K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 810 | $1K |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | <1% | 1,095 | $982.73 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 64,989 | $961.54 |
| 81003 | <1% | 293 | $960.55 | |
| 88291 | <1% | 18 | $958.66 | |
| 87181 | <1% | 330 | $899.23 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 4,615 | $891.29 |
| 95012 | <1% | 28 | $875.76 | |
| 84446 | <1% | 120 | $856.46 | |
| 94667 | <1% | 16 | $856.18 | |
| 84295 | <1% | 240 | $842.12 | |
| 87807 | <1% | 1,468 | $836.88 | |
| 85014 | <1% | 252 | $831.66 | |
| 84681 | <1% | 91 | $830.70 | |
| 88342 | <1% | 583 | $826.52 | |
| 93971 | <1% | 15 | $807.95 | |
| 90660 | <1% | 77 | $783.96 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 29,979 | $778.81 |
| 96380 | <1% | 2,376 | $771.36 | |
| 80305 | <1% | 1,181 | $763.21 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 255 | $736.31 |
| 84590 | <1% | 113 | $715.58 | |
| 93270 | <1% | 15 | $703.92 | |
| 87075 | <1% | 385 | $682.00 | |
| 82010 | <1% | 58 | $677.88 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 3,436 | $634.64 |
| 80175 | <1% | 27 | $604.97 | |
| 82435 | <1% | 807 | $604.21 | |
| 82085 | <1% | 42 | $594.46 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 9,339 | $592.22 |
| 86645 | <1% | 46 | $584.04 | |
| J0694 | Injection, cefoxitin sodium, 1 gm | <1% | 123 | $581.18 |
| 96409 | <1% | 378 | $572.07 | |
| J7510 | Prednisolone oral, per 5 mg | <1% | 2,059 | $555.89 |
| 82657 | <1% | 466 | $523.12 | |
| 82017 | <1% | 53 | $501.93 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 6,493 | $490.88 |
| 86430 | <1% | 58 | $489.29 | |
| 84302 | <1% | 952 | $468.43 | |
| 89051 | <1% | 285 | $465.24 | |
| 87101 | <1% | 95 | $454.14 | |
| 95712 | <1% | 12 | $449.29 | |
| 86644 | <1% | 37 | $437.53 | |
| 0054A | <1% | 12 | $434.20 | |
| 72220 | <1% | 52 | $433.18 | |
| 00813 | <1% | 859 | $427.18 | |
| 01730 | <1% | 16 | $415.32 | |
| 01991 | <1% | 13 | $407.41 | |
| 00635 | <1% | 63 | $407.41 | |
| 84466 | <1% | 53 | $396.85 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 682 | $394.97 |
| 00840 | <1% | 643 | $391.38 | |
| 81005 | <1% | 361 | $372.14 | |
| 93271 | <1% | 15 | $351.92 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 1,377 | $347.34 |
| 86337 | <1% | 28 | $330.91 | |
| 87102 | <1% | 152 | $319.55 | |
| 83630 | <1% | 13 | $303.25 | |
| 82951 | <1% | 13 | $298.82 | |
| 95018 | <1% | 54 | $291.19 | |
| J1953 | Injection, levetiracetam, 10 mg | <1% | 60 | $275.22 |
| 85379 | <1% | 123 | $270.94 | |
| 90840 | <1% | 988 | $251.78 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 82 | $248.39 |
| 84075 | <1% | 65 | $228.96 | |
| 86235 | <1% | 30 | $220.31 | |
| 73600 | <1% | 13 | $202.62 | |
| J9370 | Vincristine sulfate, 1 mg | <1% | 348 | $198.74 |
| 85384 | <1% | 58 | $191.09 | |
| 86774 | <1% | 33 | $186.34 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,795 | $182.85 |
| 84207 | <1% | 19 | $178.84 | |
| J0692 | Injection, cefepime hydrochloride, 500 mg | <1% | 331 | $177.99 |
| 86735 | <1% | 36 | $163.80 | |
| 99174 | <1% | 73 | $157.01 | |
| 90732 | <1% | 15 | $140.60 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 528 | $138.02 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 3,437 | $132.36 |
| 83986 | <1% | 21 | $129.49 | |
| 29125 | <1% | 70 | $127.72 | |
| 82465 | <1% | 14 | $122.62 | |
| C1769 | Guide wire | <1% | 473 | $122.43 |
| 84155 | <1% | 19 | $110.87 | |
| 85044 | <1% | 49 | $109.80 | |
| 86762 | <1% | 17 | $84.44 | |
| A4467 | Belt, strap, sleeve, garment, or covering, any type | <1% | 17 | $83.20 |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | <1% | 643 | $82.36 |
| 80230 | <1% | 79 | $80.98 | |
| 86787 | <1% | 12 | $65.31 | |
| 87581 | <1% | 19 | $62.57 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 248 | $56.27 |
| 91307 | <1% | 5,011 | $48.31 | |
| 84157 | <1% | 104 | $46.03 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 398 | $41.70 |
| 91308 | <1% | 3,105 | $28.39 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 180 | $26.53 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 113 | $25.24 |
| 81050 | <1% | 68 | $24.58 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 677 | $23.98 |
| 86039 | <1% | 12 | $23.67 | |
| 91300 | <1% | 2,115 | $20.38 | |
| 91315 | <1% | 1,612 | $14.73 | |
| 91312 | <1% | 1,561 | $14.36 | |
| 91305 | <1% | 611 | $5.79 | |
| J1171 | Injection, hydromorphone, 0.1 mg | <1% | 370 | $3.79 |
| 91317 | <1% | 458 | $2.50 | |
| 92608 | 0% | 55 | $0.00 | |
| 87116 | 0% | 28 | $0.00 | |
| 01400 | 0% | 67 | $0.00 | |
| 87206 | 0% | 28 | $0.00 | |
| 00752 | 0% | 36 | $0.00 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 0% | 19 | $0.00 |
| C1763 | Connective tissue, non-human (includes synthetic) | 0% | 32 | $0.00 |
| 01480 | 0% | 17 | $0.00 | |
| 29130 | 0% | 27 | $0.00 | |
| J1630 | Injection, haloperidol, up to 5 mg | 0% | 18 | $0.00 |
| 95873 | 0% | 152 | $0.00 | |
| 95874 | 0% | 237 | $0.00 | |
| 96159 | 0% | 480 | $0.00 | |
| 01830 | 0% | 32 | $0.00 | |
| 01470 | 0% | 12 | $0.00 | |
| 01810 | 0% | 12 | $0.00 | |
| 96402 | 0% | 14 | $0.00 | |
| 69210 | 0% | 12 | $0.00 | |
| J9260 | Injection, methotrexate sodium, 50 mg | 0% | 15 | $0.00 |
| 29105 | 0% | 13 | $0.00 | |
| 01820 | 0% | 22 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLAMANCUSA, ALICIA (DIRECTOR FINANCE)
| Provider | Location | Paid |
|---|---|---|
| Children's Hospital Medical Center of Akron | Akron, OH | $14.56M |
| Children's Hospital Medical Center of Akron | Akron, OH | $3.62M |
| Children's Hospital Medical Center of Akron | Akron, OH | $1.35M |
| Children's Hospital Medical Center of Akron | Akron, OH | $420K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.